ClinicalTrials HQ

Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Recruiting · NCT06646497 · Registry updated 2026-04-28
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 YearsBone Marrow Failure Disorders, Hemic and Lymphatic Diseases, anemia, aplastic anemia, bone marrow disorder, hematologic disorderRecruitingPhase 22026-04-28NCT06646497

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Assistance Publique - Hôpitaux de Paris985

26 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CHRU NancyNancyFrance31
CHU AmiensAmiensFrance49
CHU AngersAngersFrance87
CHU BesançonBesançonFrance32
CHU BordeauxBordeauxFrance67
CHU CaenCaenFrance48
CHU Grenoble AlpesGrenobleFrance25
CHU LilleLilleFrance63
CHU LimogesLimogesFrance42
CHU Lyon SudLyonFrance10
CHU MontpellierMontpellierFrance56
CHU NantesNantesFrance86
CHU NiceNiceFrance34
CHU PoitiersPoitiersFrance70
CHU RennesRennesFrance57
CHU Saint EtienneSaint-EtienneFrance22
CHU StrasbourgStrasbourgFrance31
CHU ToulouseToulouseFrance76
Henri BecquerelRouenFrance2
HNIA PercyClamartFrance1
Hopital Necker - APHPParisFrance1
Hôpital d'EstaingClermont-FerrandFrance2
Hôpital Henri Mondor AP-HPCréteilFrance4
Hôpital La Pitié Salpêtrière AP-HPParisFrance2
Institut Paoli CalmettesMarseilleFrance49